<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Leap Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Leap Therapeutics, Inc.

    Leap Therapeutics (NASDAQ: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator. DKN-01 is in clinical trials in patients with esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap's second clinical candidate, TRX518, is a humanized GITR agonist monoclonal antibody designed to enhance the immune system's anti-tumor response that is in advanced solid tumor studies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Chris Mirabelli, Ph.D.
    • FOUNDED
      2011
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Veru Inc.

    Veru Inc.

    Our strategy is to be known as “the prostate cancer company”. We aspire to be ...

    Our strategy is to be known as “the prostate ...

    Filing Type:    PU
    The Joint Corp.

    The Joint Corp.

    Headquartered in Scottsdale, Arizona, The Joint Chiropractic is revolutionizing ac...

    Headquartered in Scottsdale, Arizona, The Joint...

    Filing Type:    PU
    Orthogonal Thinker Inc.

    Orthogonal Thinker Inc.

    Orthogonal is a Socially Conscious Holding Company. As such, we only invest in co...

    Orthogonal is a Socially Conscious Holding Comp...

    Amount Raised:    $522,898.00
    Fundraising Status:    EC
    Filing Type:    CF
    CytomX Therapeutics, Inc.

    CytomX Therapeutics, Inc.

    CytomX Therapeutics develops Probody™ therapeutics for the treatment of cancer. ...

    CytomX Therapeutics develops Probody™ therape...

    Filing Type:    PU
    Aptorum Group Limited

    Aptorum Group Limited

    We are a pharmaceutical company currently in the preclinical stage, dedicated to d...

    We are a pharmaceutical company currently in th...

    Filing Type:    PU
    Proteon Therapeutics, Inc.

    Proteon Therapeutics, Inc.

    Proteon Therapeutics is working to deliver a new future for patients and families ...

    Proteon Therapeutics is working to deliver a ne...

    Filing Type:    PU
    Onconova Therapeutics, Inc.

    Onconova Therapeutics, Inc.

    Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused o...

    Onconova Therapeutics, Inc. is a Phase 3-stage ...

    Filing Type:    PU
    IGM Biosciences, Inc.

    IGM Biosciences, Inc.

    Headquartered in Mountain View, California, IGM Biosciences is a biotechnology com...

    Headquartered in Mountain View, California, IGM...

    Filing Type:    PU
    Infinity Pharmaceuticals, Inc.

    Infinity Pharmaceuticals, Inc.

    Infinity Pharmaceuticals, Inc. is an innovative biopharmaceutical company dedicate...

    Infinity Pharmaceuticals, Inc. is an innovative...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.